Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms

Novo Nordisk's team in India is urging the company to launch its popular weight-loss drug, Wegovy, next year to stay ahead of rival Eli Lilly. Concerns have been raised about Novo potentially lagging behind if Wegovy is not introduced before Lilly's drug, Mounjaro, in the Indian market where demand is high.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ikUSv43
via IFTTT